As of 2025-05-16, the Intrinsic Value of Avricore Health Inc (AVCR.V) is 0.05 CAD. This AVCR.V valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 0.06 CAD, the upside of Avricore Health Inc is -14.30%.
The range of the Intrinsic Value is 0.04 - 0.06 CAD
Based on its market price of 0.06 CAD and our intrinsic valuation, Avricore Health Inc (AVCR.V) is overvalued by 14.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (3.83) - (0.76) | (1.26) | -2389.2% |
| DCF (Growth 10y) | (1.37) - (6.73) | (2.24) | -4169.9% |
| DCF (EBITDA 5y) | 0.04 - 0.06 | 0.05 | -14.3% |
| DCF (EBITDA 10y) | 0.26 - 0.35 | 0.30 | 439.3% |
| Fair Value | -0.09 - -0.09 | -0.09 | -267.50% |
| P/E | (0.02) - (0.04) | (0.03) | -148.3% |
| EV/EBITDA | 0.04 - 0.05 | 0.05 | -16.3% |
| EPV | (0.08) - (0.10) | (0.09) | -265.3% |
| DDM - Stable | (0.10) - (0.67) | (0.38) | -798.2% |
| DDM - Multi | (0.04) - (0.20) | (0.07) | -219.1% |
| Market Cap (mil) | 5.57 |
| Beta | 1.59 |
| Outstanding shares (mil) | 101.29 |
| Enterprise Value (mil) | 4.44 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.74% |
| Cost of Debt | 5.00% |
| WACC | 6.71% |